These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9023661)

  • 1. In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
    Martinez-Martinez L; Rodriguez G; Pascual A; Suárez AI; Perea EJ
    J Antimicrob Chemother; 1996 Dec; 38(6):1107-8. PubMed ID: 9023661
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
    Bello H; Gonzalez G; Dominguez M; Zemelman R; Garcia A; Mella S
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):183-6. PubMed ID: 9327246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G; Zarakolu P; Hasçelik G; Akova M
    Mikrobiyol Bul; 2006; 40(1-2):23-8. PubMed ID: 16775953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ
    Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies.
    Traub WH; Geipel U; Schwarze I; Bauer D
    Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
    Xirouchaki E; Giamarellou H
    J Chemother; 1992 Oct; 4(5):263-7. PubMed ID: 1479414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
    Sood P; Mandal A; Mishra B
    Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
    Int J Antimicrob Agents; 2021 May; 57(5):106344. PubMed ID: 33857539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.
    Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M
    J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
    Rolston KV; Elting L; Waguespack S; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1996; 42(5):348-53. PubMed ID: 8874974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Valero E; Sevillano D; Calvo A; García R; Leturia A; Gómez-Lus ML
    Rev Esp Quimioter; 2001 Dec; 14(4):358-63. PubMed ID: 11856982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I; Nagy E
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
    Mimoz O; Jacolot A; Leotard S; Hidri N; Samii K; Nordmann P; Petitjean O
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3304-8. PubMed ID: 9835534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood.
    Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1995 Nov; 23(3):105-110. PubMed ID: 8849654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    Gerçeker AA; Gürler B
    J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
    Elkhaïli H; Pompei D; Linger L; Kamili N; Monteil H; Jehl F
    Pathol Biol (Paris); 1996 May; 44(5):367-73. PubMed ID: 8758478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Bonacorsi S; Fitoussi F; Lhopital S; Bingen E
    Antimicrob Agents Chemother; 1999 Feb; 43(2):213-7. PubMed ID: 9925508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.